Andere talen Roche Holding AG Swiss Exchange

Aandelen

RO

CH0012032113

Beurs gesloten - Swiss Exchange Andere beurzen 17:30:41 31-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
252,8 ^CHF	+1,04%		+0,32%	-3,29%

31/05	ROCHE HOLDINGS AG : UBS vindt het aandeel niet inspirerend	ZD
31/05	Transcript : Roche Holding AG - Shareholder/Analyst Call

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ROCHE HOLDINGS AG : Gets a Neutral rating from UBS	31/05
Transcript : Roche Holding AG - Shareholder/Analyst Call	31/05
ROCHE HOLDINGS AG : Goldman Sachs remains a Sell rating	30/05
Swiss Stocks Fall as Rate Jitters Intensify Amid Latest Inflation Data	29/05
Roche's Metastatic Breast Cancer Treatment Granted Priority Review by US FDA	29/05
Roche Holding AG Announces U.S. Food and Drug Administration Accepted the New Drug Application and Granted Priority Review to Inavolisib, an Investigational, Oral Therapy, in Combination with Palbociclib (Ibrance®) and Fulvestrant	29/05
Roche and Hitachi High-Tech Extend Their 46-Year Partnership, Paving the Way for Further Breakthroughs in Diagnostic Testing	27/05
Roche Announces Management and Board Committee Changes	27/05
Swiss Market Index Slumps as Economic Data Triggers Rate Jitters Anew	24/05
ROCHE HOLDINGS AG : Gets a Neutral rating from Deutsche Bank	24/05
UK Watchdog Launches Probe into Roche's LumiraDx Purchase	24/05
Transcript : Roche Holding AG - Analyst/Investor Day	22/05
Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test	22/05
Roche Receives FDA Device Designation for Blood Test Measuring Lp(a)	22/05
Europe stock pickers go old-school to ride the next wave in AI	22/05
Roche's Investigational Breast Cancer Treatment Granted Breakthrough Designation by US FDA	21/05
FDA Grants Breakthrough Therapy Designation to Roche's Inavolisib for Advanced Hormone Receptor-Positive, Hormone-Positive, Hormon Receptor 2-Negative Breast Cancer with A PIK3CA Mutation	21/05
UK Competition Watchdog Considers Probe into Roche's Purchase of LumiraDx Business	20/05
UK'S CMA: INVITES COMMENTS ON ROCHE / LUMIRADX DEAL FROM ANY IN…	20/05
ROCHE HOLDINGS AG : UBS sticks Neutral	17/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

ROCHE HOLDING : In lijn kwartaalresultaten niet voldoende voor Roche

24 april 2024 om 17:50 uur

Obesitas: Roche betreedt het strijdtoneel

05 december 2023 om 11:27 uur